Free Trial

LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts

LeMaitre Vascular logo
$110.22 -1.78 (-1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$110.08 -0.14 (-0.13%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LeMaitre Vascular Earnings Summary

LeMaitre Vascular posted Q1 2026 earnings on May 5, 2026, reporting an EPS of $0.68, which topped the consensus estimate of $0.66 by $0.02. Quarterly revenue rose 11.1% year-over-year to $66.55 million, below the consensus estimate of $66.67 million. With a trailing EPS of $2.51 and a P/E Ratio of 40.67, LeMaitre Vascular's earnings are expected to grow 10.38% next year, from $2.89 to $3.19 per share.

Latest Q1
Earnings Date
May. 5Estimated
Consensus EPS
(May. 5)
$0.66
Actual EPS
(May. 5)
$0.68 Beat By $0.02
Actual Revenue
(May. 5)
$66.55M

Q1 2026 Earnings Resources

Get LeMaitre Vascular Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LeMaitre Vascular and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LMAT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LMAT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LeMaitre Vascular Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20262$0.60$0.62$0.61$65.9 M0.640 - 0.690$65.6 M - $67.6 M
Q2 20262$0.69$0.70$0.70$71.5 M0.790 - 0.840$70.5 M - $72.5 M
Q3 20262$0.61$0.63$0.62
Q4 20262$0.62$0.65$0.64

LeMaitre Vascular Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026$0.66$0.68+$0.02$0.68$66.67M$66.55M
2/25/2026Q4 2025$0.67$0.68+$0.01$0.68$62.98M$64.45M
11/6/2025Q3 2025$0.57$0.62+$0.05$0.75$62.18M$61.05M
8/5/2025Q2 2025$0.57$0.60+$0.03$0.60$62.48M$63.15M
5/1/2025Q1 2025$0.50$0.48 -$0.02$0.48$57.61M$59.87M
2/27/2025Q4 2024$0.49$0.49-$0.49$55.99M$55.81M
10/31/2024Q3 2024$0.44$0.49+$0.05$0.49$53.50M$54.82M
8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98M$55.85M

Data powered by Fiscal.ai.

LeMaitre Vascular Earnings - Frequently Asked Questions

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earning data on Tuesday, May 5, 2026. Learn more on LMAT's earnings history.

LeMaitre Vascular updated its second quarter 2026 earnings guidance on Tuesday, May, 5th. The company provided earnings per share guidance of 0.790-0.840 for the period, compared to the consensus earnings per share estimate of 0.760. The company issued revenue guidance of $70.5 million-$72.5 million, compared to the consensus revenue estimate of $71.5 million.

In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $0.66 by $0.02. Learn more on analysts' earnings estimate vs. LMAT's actual earnings.

The conference call for LeMaitre Vascular's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for LeMaitre Vascular's latest earnings report can be read online.
Read Transcript

LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $249.60 million.

LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $57.73 million. LMAT has generated $2.51 earnings per share over the last four quarters.

LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 40.67 and a forward price-to-earnings ratio of 38.14. The price/earnings-to-growth ratio is 3.23.

LeMaitre Vascular's earnings are expected to grow from $2.89 per share to $3.19 per share in the next year, which is a 10.38% increase.


This page (NASDAQ:LMAT) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners